Back

Blood pressure response to exercise in endurance athletes with and without paroxysmal atrial fibrillation.

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Clinical implications of catheter ablation techniques Atrial Stressors ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Ms Kristel Janssens

St Kilda East (Australia)

8 More presentations in this session

Presentation thumbnail
"Honey pot"-like lesion formation: impact of catheter contact angle on lesion formation by novel temperature controlled ablation catheter in a porcine experimental model
Doctor S. Ogiso (Kanagawa, JP)
Abstract Slides Video
Presentation thumbnail
Evaluating lesion integrity with diamond temp system
Doctor A. Khanani (Lakeland, US)
Abstract Slides Video
Presentation thumbnail
Risk of right coronary artery injury and distance from tricuspid valve ring to right coronary artery in radiofrequency ablation.
Mr M. Takigawa (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Anatomical characteristics of the phrenic nerve and the spontaneous conduction block between the right atrium and the superior vena cava
Doctor R. Hojo (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Valvular leaflets and epicardial fat have a significant effect on lesion size in RF ablation
Miss C. Colling (Munich, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Clinical implications of catheter ablation techniques

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Atrial fibrillation and endurance sport: what is the link?
thumbnail
Congress Presentation
Atrial and ventricular arrhythmias in young, lifelong and retired elite endurance athletes
thumbnail
Congress Presentation
Differences in cardiac magnetic resonance imaging bi-atrial strain between elite athletes and atrial fibrillation patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources